Stromal cells in hemangioblastoma: Neuroectodermal differentiation and morphological similarities to ependymoma

Pathology International

Volumn 55, Issue 7, 2005, Pages 377-385

  Ishizawa, Keisuke ^a   Komori, Takashi ^b   Hirose, Takanori ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Cerebellum; Ependymoma; Glial fibrillary acidic protein; Hemangioblastoma; Neuroectodermal differentiation; Stromal cell

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; CD99 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EMBRYO DEVELOPMENT; EPENDYMOMA; EPITHELIOID CELL; FEMALE; GLIA CELL; HEMANGIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVILLUS; NEUROECTODERM; PRIORITY JOURNAL; SCHOOL CHILD; STROMA CELL; TUMOR CELL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD57; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CEREBELLAR NEOPLASMS; CHILD; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; EPENDYMOMA; FEMALE; HEMANGIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUROECTODERMAL TUMORS; PHOSPHOPROTEINS; PHOSPHOPYRUVATE HYDRATASE; S100 PROTEINS; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VIMENTIN;

EID: 23244438102     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01841.x     Document Type: Article

References (46)

1. Bohling T, Plate KH, Haltia MJ, Alitalo K, Neumann HPH. Von Hippel-Lindau disease and capillary haemangioma. In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000; 223-6.
2. Lantos PL, Louis DN, Rosenblum MK, Kleihues P. Tumours of the nervous system. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology, 7th edn. London: Arnold, 2002; 767-1052.
3. Hasselblatt M, Paulus W. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas. Acta Neuropathol 2003; 106: 385-8.
4. Chaudhry AP, Montes M, Cohn GA. Ultrastructure of cerebellar hemangioblastoma. Cancer 1978; 42: 1834-50.
5. Ho KL. Ultrastructure of cerebellar capillary hemangioblastoma. I. Weibel-Palade bodies and stromal cell histogenesis. J Neuropathol Exp Neurol 1984; 43: 592-608.
6. Jurco SI, Nadji M, Harvey DG, Parker JC Jr, Font RL, Morales AR. Hemangioblastomas: Histogenesis of the stromal cell studied by immunocytochemistry. Hum Pathol 1982; 13: 13-18.
7. Kamitani H, Masuzawa H, Sato J, Kanazawa I. Capillary hemangioblastoma: Histogenesis of stromal cells. Acta Neuropathol 1987; 73: 370-8.
8. Lach B, Gregor A, Rippstein P, Omulecka A. Angiogenic histogenesis of stromal cells in hemangioblastoma: Ultrastructural and immunohistochemical study. Ultrastruct Pathol 1999; 23: 299-310.
9. Omulecka A, Lach B, Alwasiak J, Gregor A. Immunohistochemical and ultrastructural studies of stromal cells in hemangioblastoma. Folia Neuropathol 1995; 33: 41-50.
10. Spence AM, Rubinstein LJ. Cerebellar capillary hemangioblastoma: Its histogenesis studied by organ culture and electron microscopy. Cancer 1975; 35: 326-41.
11. Nemes Z. Fibrohistiocytic differentiation in capillary hemangioblastoma. Hum Pathol 1992; 23: 805-10.
12. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: An undifferentiated mesenchymal tumor. Mod Pathol 1989;2:638-51.
13. Becker I, Paulus W, Roggendorf W. Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study. Am J Pathol 1989; 134: 271-5.
14. Ismail SM, Jasani B, Cole G. Histogenesis of haemangioblastomas: An immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome. J Clin Pathol 1985; 38: 417-21.
15. Ironside JW, Stephenson TJ, Royds JA et al. Stromal cells in cerebellar haemangioblastomas: An immunocytochemical study. Histopathology 1988; 12: 29-40.
16. Kepes JJ, Rengachary SS, Lee SH. Astrocytes in hemangioblastomas of the central nervous system and their relationship to stromal cells. Acta Neuropathol 1979; 47: 99-104.
17. Tanimura A, Nakamura Y, Hachisuka H, Tanimura Y, Fukumura A. Hemangioblastoma of the central nervous system: Nature of the stromal cells as studied by the immunoperoxidase technique. Hum Pathol 1984; 15: 866-9.
18. Adams SA, Hilton DA. Recurrent haemangioblastoma with glial differentiation. Neuropathol Appl Neurobiol 2002; 28: 142-6.
19. Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol 1987; 88: 286-96.
20. Schnitzer J, Franke WW, Schachner M. Immunocytochemical demonstration of vimentin in astrocytes and ependymal cells of developing and adult mouse nervous system. J Cell Biol 1981; 90: 435-47 .
21. Bodega G, Suarez I, Rubio M, Fernandez B. Ependyma: Phylogenetic evolution of glial fibrillary acidic protein (GFAP) and vimentin expression in vertebrate spinal cord. Histochemistry 1994; 102: 113-22.
22. Cerilli LA, Wick MR. Immunohistochemistry of soft tissue and osseous neoplasms. In: Dabbs DJ, ed. Diagnostic Immunohistochemistry. Philadelphia: Churchill Livingstone, 2002; 59-112.
23. Vaheri A, Carpen O, Heiska L et al. The ezrin protein family: Membrane-cytoskeleton interactions and disease associations. Curr Opin Cell Biol 1997; 9: 659-66.
24. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993; 105: 1025-43.
25. Geiger KD, Stoldt P, Schlote W, Derouiche A. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000; 157: 1785-93.
26. Bohling T, Turunen O, Jaaskelainen J et al. Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. Am J Pathol 1996; 148: 367-73.
27. Feickert HJ, Pietsch T, Hadam MR, Mildenberger H, Riehm H. Monoclonal antibody T-199 directed against human medulloblastoma: Characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells. Cancer Res 1989; 49: 4338-43.
28. Bohling T, Maenpaa A, Timonen T, Vantunen L, Paetau A, Haltia M. Different expression of adhesion molecules on stromal cells and endothelial cells of capillary hemangioblastoma. Acta Neuropathol 1996; 92: 461-6.
29. Fukunaga M, Ushigome S. Small cell (oat cell) carcinoma of the breast. Pathol Int 1998; 48: 744-8.
30. Hirose T, Hasegawa T, Kudo E, Seki K, Sano T, Hizawa K. Malignant peripheral nerve sheath tumors: An immunohistochemical study in relation to ultrastructural features. Hum Pathol 1992; 23: 865-70.
31. McNerlan SE, Rea IM, Alexander HD, Morris TC. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol 1998; 18: 31-8.
32. Hufnagel TJ, Kim JH, True LD, Manuelidis EE. Immunohistochemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma. Am J Surg Pathol 1989; 13: 207-16.
33. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody 013: Antibody that recognizes glycoprotein p30/ 32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994; 18: 486-94.
34. Choi YL, Chi JG, Suh YL. CD99 immunoreactivity in ependymoma. Appl Immunohistochem Mol Morph 2001; 9: 125-9.
35. Cooper EH. Neuron-specific enolase. Int J Biol Markers 1994; 9: 205-10.
36. Grant JW, Gallagher PJ, Hedinger C. Haemangioblastoma. An immunohistochemical study of ten cases. Acta Neuropathol 1988; 76: 82-6.
37. Hatva E, Bohling T, Jaaskelainen J, Persico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 1996; 148: 763-75.
38. Machein MR, Plate KH. VEGF in brain tumors. J Neurooncol 2000; 50: 109-20.
39. Deck JH, Rubinstein LJ. Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: Significance and possible implications of an immunoperoxidase study. Acta Neuropathol 1981; 54: 173-81.
40. Burger PC, Scheithauer BW. Tumors of the central nervous system. In: Burger PC, Scheithauer BW, eds. Atlas of Tumor Pathology, 3rd series, fascicle 10. Washington, DC: Armed Forces Institute of Pathology, 1993; 239-49.
41. Wiestler OD, Schiffer D, Coons SW, Prayson RA, Rosenblum MK. Ependymoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000; 72-6.
42. Burger PC, Scheithauer BW, Vogel FS. The Brain: Tumors. In: Burger PC, Scheithauer BW, Vogel FS, eds. Surgical Pathology of the Nervous System and its Coverings. Philadelphia: Churchill Livingstone, 2002; 160-378.
43. Erlandson RA. Ultrastructural features of specific human neoplasms with clinicopathologic, immunohistochemical, and cytogenetic correlations. In: Erlandson RA, ed. Diagnostic Transmission Electron Microscopy of Tumors. New York: Raven Press, 1994;243-832.
44. Bonnin JM, Pena CE, Rubinstein LJ. Mixed capillary hemangioblastoma and glioma. A redefinition of the 'angioglioma'. J Neuropathol Exp Neurol 1983; 42: 504-16.
45. Kawano N, Yagishita S, Komatsu K et al. Cerebellar clear cell ependymoma mimicking hemangioblastoma: Its clinical and pathological features. Surg Neurol 1999; 51: 281-7.
46. Kawano N, Yada K, Yagishita S. Clear cell ependymoma. A histological variant with diagnostic implications. Virchows Arch Pathol Anat 1989; 415: 467-72.